TRAITEMENT DE LA SCLÉROSE EN PLAQUES PAR LE LAQUINIMOD

• 收藏
• 分享

专利权人:

TEVA PHARMACEUTICAL INDUSTRIES; LTD.

发明人:

申请号：

EP15178731.4

公开号：

EP3028572A1

申请日:

2010.06.18

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the method comprising orally administering to the patient a daily dose of 0.6 mg laquinimod.The subject invention also provides for pharmaceutical oral unit dosage forms of 0.6 mg laquinimod for use in reducing the relapse rate and/or for use in reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/